---
title: "Shingrix (Zoster Vaccine Recombinant, Adjuvanted), all indications: Dosing and administration questions"
description: "Dosing and administration questions on Shingrix (Zoster Vaccine Recombinant, Adjuvanted) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Dosing, Administration, and Preparation. Questions: Why does Shingrix require two doses? How is Shingrix given (dose and injection site)? What should Shingrix look like before it is given? How do you reconstitute Shingrix vials (vial and vial presentation)? 2 further questions follow. 6 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/shingrix/dosing-and-administration"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Shingrix (Zoster Vaccine Recombinant, Adjuvanted), all indications: Dosing and administration questions

Manufacturer: GlaxoSmithKline Biologicals; GlaxoSmithKline  
Prescribing information: [Shingrix](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF)  
Indication pages: [Herpes zoster prevention](https://www.evicenter.com/medical-information/shingrix--herpes-zoster-prevention)

## Dosing

<a id="shingrix-both-doses"></a>

### Why does Shingrix require two doses?

> “It is important to receive both doses. The efficacy results of SHINGRIX were demonstrated in clinical trials when administered as a 2-dose series.<sup>1</sup>”

Source: [SHINGRIX: Storage & Dosing, captured 2026-11-14](https://shingrixhcp.com/home-ic/in-your-practice/storage-and-dosing/#:~:text=It%20is%20important%20to%20receive,when%20administered%20as%20a%202%2Ddose)

## Administration

<a id="shingrix-injection-site"></a>

### How is Shingrix given (dose and injection site)?

> “Administer a single 0.5-mL dose by intramuscular injection. The preferred site for intramuscular injection is the 
> deltoid region of the upper arm.”

Source: [SHINGRIX: Prescribing information, page 3, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=3)

<a id="shingrix-vaccine-information-statement"></a>

### Where is the Shingrix Vaccine Information Statement?

> “• Provide the Vaccine Information Statements, which are available free of charge at the Centers for Disease 
> Control and Prevention (CDC) website (www.cdc.gov/vaccines).”

Source: [SHINGRIX: Prescribing information, page 26, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=26)

## Preparation

<a id="shingrix-appearance"></a>

### What should Shingrix look like before it is given?

> “SHINGRIX is an opalescent, colorless to pale brownish liquid. Parenteral drug products should be inspected 
> visually for particulate matter and discoloration prior to administration, whenever solution and container permit. 
> If either of these conditions exists, the vaccine should not be administered.”

Source: [SHINGRIX: Prescribing information, page 3, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=3)

<a id="shingrix-reconstitution"></a>

### How do you reconstitute Shingrix vials (vial and vial presentation)?

> “Reconstitute the Lyophilized gE Antigen Component (a sterile white powder) with the accompanying Adjuvant 
> Suspension Component (an opalescent, colorless to pale brownish liquid) to form SHINGRIX. Use only the 
> supplied Adjuvant Suspension Component for reconstitution. See Figures 1 through 4.”

Source: [SHINGRIX: Prescribing information, page 2, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=2)

> “Figure 1. Cleanse both 
> vial stoppers. Using a 
> sterile needle 
> appropriate for 
> administering a vaccine 
> intramuscularly and a 
> sterile syringe, 
> withdraw the entire 
> contents of the vial 
> containing the 
> Adjuvant Suspension 
> Component (liquid) by 
> slightly tilting the vial. 
> Vial 1 of 2. 
> Figure 2. Slowly 
> transfer entire contents 
> of syringe into the 
> Lyophilized gE 
> Antigen Component 
> vial (powder). Vial 2 of 
> 2. 
> Figure 3. Gently swirl the 
> vial until powder is 
> completely dissolved. Do 
> not shake vigorously. 
> Figure 4. After 
> reconstitution, withdraw 
> 0.5 mL from the vial 
> containing the 
> reconstituted vaccine and 
> administer 
> intramuscularly.”

Source: [SHINGRIX: Prescribing information, page 3, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=3)

> “After reconstitution, administer SHINGRIX immediately or store refrigerated between 2° and 8°C (36° and 
> 46°F) and use within 6 hours. Discard reconstituted vaccine if not used within 6 hours.”

Source: [SHINGRIX: Prescribing information, page 3, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=3)

Note: The figure captions are printed beside the four illustrations in the Prescribing Information and are read in order, Figure 1 through Figure 4.

<a id="shingrix-prefilled-syringe"></a>

### Does the Shingrix prefilled syringe need reconstitution?

> “The prefilled syringe contains SHINGRIX and does not require reconstitution before use.”

Source: [SHINGRIX: Prescribing information, page 2, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=2)

> “Attach a sterile needle to the prefilled syringe and administer SHINGRIX intramuscularly.”

Source: [SHINGRIX: Prescribing information, page 3, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=3)

> “SHINGRIX is available as 0.5-mL single-dose, disposable, prefilled TIP-LOK syringes (Luer Lock syringes) 
> packaged without needles. TIP-LOK syringes are to be used with Luer Lock compatible needles.”

Source: [SHINGRIX: Prescribing information, page 25, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=25)

## Related pages
- [Medical information: Shingrix (Zoster Vaccine Recombinant, Adjuvanted): All indications](https://www.evicenter.com/medical-information/shingrix)
- [Indication](https://www.evicenter.com/medical-information/shingrix/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/shingrix/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/shingrix/safety)
- [Specific populations](https://www.evicenter.com/medical-information/shingrix/specific-populations)
- [Storage and supply](https://www.evicenter.com/medical-information/shingrix/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/shingrix/access-and-coverage)
- [Guidelines](https://www.evicenter.com/medical-information/shingrix/guidelines)
